You have 9 free searches left this month | for more free features.

lncRNA, mRNA, ESWL,PCNL,SBF2-AS1, FENDRR-19, NLRP3.

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urinary Calculi, Percutaneous Nephrolithotomy Trial in Hengyang (Without reverse insertion of a ureteral catheter)

Recruiting
  • Urinary Calculi
  • Percutaneous Nephrolithotomy
  • Without reverse insertion of a ureteral catheter
  • Hengyang, Hunan, China
    The First Affiliated Hospital of University of South China
Nov 6, 2022

SARS-CoV-2 Trial (SARS-CoV-2 mRNA Vaccine, Bivalent Low dose, SARS-CoV-2 mRNA Vaccine, Bivalent High dose, Placebo)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA Vaccine, Bivalent Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, mRNA-1273)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01E
  • mRNA-1273
  • (no location specified)
Apr 25, 2022

Pancreatic Duct Stone, ESWL, Fasting Trial in Shanghai (Early feeding group, Standard fasting group)

Not yet recruiting
  • Pancreatic Duct Stone
  • +2 more
  • Early feeding group
  • Standard fasting group
  • Shanghai, China
    Changhai Hospital
Dec 20, 2022

Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

Not yet recruiting
  • Vaccine Reaction
  • COVID-19
  • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
  • VidPrevtyn® Beta vaccine (Sanofi/GSK)
  • Paris, France
    CIC 1417 Cochin-Pasteur
Feb 28, 2023

Coronavirus Infections, Pneumonia, Viral Trial in Parma (Colchicine)

Completed
  • Coronavirus Infections
  • Pneumonia, Viral
  • Parma, PR, Italy
    Azienda Ospedaliero Universitaria di Parma
Jul 19, 2022

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

SARS-CoV-2 Trial in Bengbu (COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose, COVID-19 Variant (Omicron BA.5) mRNA Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Pandemic Trial (Lyophilized COVID-19 mRNA Vaccine, Sodium chloride)

Not yet recruiting
  • COVID-19 Pandemic
  • Lyophilized COVID-19 mRNA Vaccine
  • Sodium chloride
  • (no location specified)
Nov 18, 2022

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Recombinant COVID-19 variant Vaccine (Sf9 Cell)
  • +3 more
  • Morelia, Michoacán De Ocampo, Mexico
    Clínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022

Severe Exacerbation of Severe Acute Respiratory Syndrome

Active, not recruiting
  • SARS-CoV-2
    • Tokyo, Japan
      CMIC Co. Ltd.,
    Jun 5, 2023

    Kidney Stone, Ureteral Stone Trial in Denmark, Portugal, United States (SOLTIVE™ Premium SuperPulsed Laser Fiber System)

    Recruiting
    • Kidney Stone
    • Ureteral Stone
    • SOLTIVE™ Premium SuperPulsed Laser Fiber System
    • Phoenix, Arizona
    • +6 more
    Jan 16, 2023

    Japan After Severe Acute Respiratory Syndrome Coronavirus 2

    Not yet recruiting
    • SARS-CoV-2
      • Tokyo, Japan
        CMIC Co., Ltd
      Jun 6, 2023

      Gout Arthritis Trial in Lyon

      Not yet recruiting
      • Gout Arthritis
        • Lyon, France
          Centre Hospitalier Saint Joseph Saint Luc
        Feb 22, 2023

        COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

        Not yet recruiting
        • COVID-19
        • XBB.1.5 Vaccine (Booster)
        • XBB.1.5 Vaccine (single dose)
        • Mobile, Alabama
        • +29 more
        Aug 4, 2023

        SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

        Active, not recruiting
        • SARS-CoV-2
        • Influenza
        • mRNA-1073
        • +3 more
        • Hollywood, Florida
        • +13 more
        Oct 5, 2022

        Chronicization of Radiation-induced Acute Intestinal Injury

        Not yet recruiting
        • Radiation-induced Intestinal Injury
        • NCRT+TME
        • (no location specified)
        Feb 19, 2023

        Antibody Response to COVID19 Vaccination in Multiple Sclerosis

        Completed
        • Multiple Sclerosis
        • Covid19
          • Livingston, New Jersey
            Saint Barnabas Medical Center
          Aug 16, 2022

          COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

          Not yet recruiting
          • COVID-19 Vaccine
          • COVID-19
          • 50 μg Baiya SARS-CoV-2 Vax 2
          • Placebo
          • Bangkok, Thailand
            Queen Saovabha Memorial Institute
          May 23, 2023

          Advanced Gastric Carcinoma, Immunotherapy Trial in Beijing (Circulating exosomal lncRNA-GC1 detection)

          Completed
          • Advanced Gastric Carcinoma
          • Immunotherapy
          • Circulating exosomal lncRNA-GC1 detection
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Oct 7, 2022

          SARS-CoV-2 Trial (LVRNA009, 0.9%NaCl)

          Not yet recruiting
          • SARS-CoV-2
          • LVRNA009
          • 0.9%NaCl
          • (no location specified)
          Jan 11, 2023

          SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)

          Not yet recruiting
          • SARS-CoV2 Infection
          • Coronavirus Infection
          • Hamilton, Ontario, Canada
            McMaster University
          Jun 29, 2022

          Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)

          Recruiting
          • Pneumococcal Infection
          • V110
          • +4 more
          • North Hollywood, California
          • +45 more
          Aug 11, 2022